LIFE
Ethos Technologies Inc. Class A Common StockNASDAQFINANCIAL SERVICESINSURANCE BROKERS
Key Statistics
Market Cap
$1.68B
P/E Ratio
—
EPS
$-1.71
Beta
—
52W High
$32.50
52W Low
$9.45
50-Day MA
$16.42
200-Day MA
$14.87
Dividend Yield
—
Profit Margin
-22.10%
Forward P/E
—
PEG Ratio
—
About Ethos Technologies Inc. Class A Common Stock
aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $485.82M |
| Gross Profit (TTM) | $477.43M |
| EBITDA | $-97.46M |
| Operating Margin | -84.60% |
| Return on Equity | -29.10% |
| Return on Assets | -11.80% |
| Revenue/Share (TTM) | $19.86 |
| Book Value | $9.17 |
| Price-to-Book | 2.53 |
| Price-to-Sales (TTM) | 3.46 |
| EV/Revenue | 2.004 |
| EV/EBITDA | 17.25 |
| Quarterly Earnings Growth (YoY) | 161.60% |
| Quarterly Revenue Growth (YoY) | 103.50% |
| Shares Outstanding | $30.91M |
| Float | $26.02M |
| % Insiders | 6.45% |
| % Institutions | 74.22% |
Historical Volatility
HV 10-Day
109.74%
HV 20-Day
151.36%
HV 30-Day
124.76%
HV 60-Day
98.12%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($27.00 target)
3
Strong Buy6
BuyMore FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026